AbbVie’s Skyrizi retakes top TV ad spending spot for the first time all year
After a 2024 in which AbbVie’s Skyrizi boasted the highest TV drug ad spending outlay on seven of our monthly roundups—and took second place in four more—the immunology med has seen that dominance slip in 2025.
